Medium & long-chain acylcarnitine’s relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study

[1]  Luke W Johnston,et al.  Metabolomic profiling of the Dietary Approaches to Stop Hypertension diet provides novel insights for the nutritional epidemiology of type 2 diabetes mellitus , 2021, British Journal of Nutrition.

[2]  Shuo Huang,et al.  Zinc attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury by activating Nrf2/GPX4 defense pathway , 2021, CNS neuroscience & therapeutics.

[3]  Xiaojun He,et al.  Acetate, a Short-Chain Fatty Acid, Acutely Lowers Heart Rate and Cardiac Contractility Along with Blood Pressure , 2021, The Journal of Pharmacology and Experimental Therapeutics.

[4]  Zhongqun Wang,et al.  Galectin-3 Mediates Cardiac Remodeling Caused by Impaired Glucose and Lipid Metabolism Through Inhibiting Two Pathways of Activating Akt. , 2020, American journal of physiology. Heart and circulatory physiology.

[5]  J. He,et al.  A targeted metabolomic profiling of plasma acylcarnitines in nonalcoholic fatty liver disease. , 2020, European review for medical and pharmacological sciences.

[6]  Dongli Li,et al.  Antiobesity and anti-inflammation effects of Hakka stir-fried tea of different storage years on high-fat diet-induced obese mice model via activating the AMPK/ACC/CPT1 pathway , 2020, Food & nutrition research.

[7]  E. Oxford,et al.  Review of canine dilated cardiomyopathy in the wake of diet-associated concerns , 2020, Journal of animal science.

[8]  S. Spiegel,et al.  Functional analysis of molecular and pharmacological modulators of mitochondrial fatty acid oxidation , 2020, Scientific Reports.

[9]  V. Aboyans,et al.  Heart failure and its complications in patients with diabetes: Mounting evidence for a growing burden , 2019, European journal of preventive cardiology.

[10]  D. Lauffenburger,et al.  Fatty Acid Metabolites Combine with Reduced β Oxidation to Activate Th17 Inflammation in Human Type 2 Diabetes. , 2019, Cell metabolism.

[11]  C. Lemaire,et al.  Disturbed Fatty Acid Oxidation, Endoplasmic Reticulum Stress, and Apoptosis in Left Ventricle of Patients With Type 2 Diabetes , 2019, Diabetes.

[12]  P. Gargiulo,et al.  Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications. , 2019, Heart failure clinics.

[13]  T. Salomon,et al.  The effect of n-3 long-chain polyunsaturated fatty acids and lipoic acid on the heart in the ovariectomized rat model of menopause , 2019, Free radical research.

[14]  J. Borén,et al.  Plin2-deficiency reduces lipophagy and results in increased lipid accumulation in the heart , 2019, Scientific Reports.

[15]  Daowen Wang,et al.  MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα , 2019, Cardiovascular Diabetology.

[16]  E. Abel,et al.  Heart Failure in Type 2 Diabetes Mellitus. , 2019, Circulation research.

[17]  Yunlong Bai,et al.  Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy , 2018, Cell Death & Disease.

[18]  A. A. Abd El-Aty,et al.  METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice , 2018, Experimental & Molecular Medicine.

[19]  Kunal Sikder,et al.  High Fat Diet Upregulates Fatty Acid Oxidation and Ketogenesis via Intervention of PPAR- γ , 2018, Cellular Physiology and Biochemistry.

[20]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. , 2018, Diabetes research and clinical practice.

[21]  S. Ferdinandusse,et al.  Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle , 2018, Reviews in Endocrine and Metabolic Disorders.

[22]  R. Kamps,et al.  Human embryonic stem cell-derived cardiomyocytes as an in vitro model to study cardiac insulin resistance. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[23]  Publisher's Note , 2018, Anaesthesia.

[24]  Xiujuan Li,et al.  SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice , 2017, Oxidative medicine and cellular longevity.

[25]  Yingmei Zhang,et al.  Sirt3 deficiency exacerbates diabetic cardiac dysfunction: Role of Foxo3A-Parkin-mediated mitophagy. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[26]  Wang-Soo Lee,et al.  Diabetic cardiomyopathy: where we are and where we are going , 2017, The Korean journal of internal medicine.

[27]  J. Egido,et al.  Diagnostic approaches for diabetic cardiomyopathy , 2017, Cardiovascular Diabetology.

[28]  J. Sowers,et al.  Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease , 2017, Diabetologia.

[29]  Zhitu Zhu,et al.  A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detection , 2016, OncoTargets and therapy.

[30]  E. Maratos-Flier,et al.  Understanding the Physiology of FGF21. , 2016, Annual review of physiology.

[31]  P. A. Wood,et al.  Carnitine Palmitoyltransferase-1b Deficiency Aggravates Pressure Overload–Induced Cardiac Hypertrophy Caused by Lipotoxicity , 2012, Circulation.

[32]  U. Laufs,et al.  Metabolic Switch and Hypertrophy of Cardiomyocytes following Treatment with Angiotensin II Are Prevented by AMP-activated Protein Kinase* , 2008, Journal of Biological Chemistry.

[33]  N. Ruderman,et al.  Acute Regulation of Fatty Acid Oxidation and AMP-Activated Protein Kinase in Human Umbilical Vein Endothelial Cells , 2001, Circulation research.